Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity

v3.21.1
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
Series D Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2018 $ 5 $ 26,118 $ 175,924,587 $ (159,856,481) $ 16,094,229
Balance, shares at Dec. 31, 2018 5,141 26,118,075        
Stock-based compensation $ 72 424,341 424,413
Stock-based compensation, shares 71,724        
Restricted stock issued in satisfaction of accrued issuable equity $ 136 380,995 381,131
Restricted stock issued in satisfaction of accrued issuable equity, shares 135,722        
Common stock issued upon conversion of Series D convertible preferred stock $ 5 (5)
Common stock issued upon conversion of Series D convertible preferred stock, shares (16) 5,128        
Return and retirement of common stock   $ (8) 8
Return and retirement of common stock, shares   (8,066)        
Other comprehensive income       183,173 183,173
Net loss       (9,648,500) (9,648,500)
Balance at Dec. 31, 2019 $ 5 $ 26,323 176,729,926 183,173 (169,504,981) 7,434,446
Balance, shares at Dec. 31, 2019 5,125 26,322,583        
Stock-based compensation $ 131 882,738 882,868
Stock-based compensation, shares 130,722        
Common stock issued upon conversion of Series D convertible preferred stock $ (5) $ 1,643 (1,638)
Common stock issued upon conversion of Series D convertible preferred stock, shares (5,125) 1,642,628        
Common stock issued in public offering [1]   $ 3,598 19,171,948 19,175,546
Common stock issued in public offering, shares [1]   3,597,833        
Common stock issued upon exercise of warrants   $ 3,827 16,260,860 16,264,687
Common stock issued upon exercise of warrants, shares   3,827,181        
Common stock issued in satisfaction of accrued issuable equity   $ 102 200,817 200,920
Common stock issued in satisfaction of accrued issuable equity, shares   102,402        
Common stock issued as consideration for acquisition   $ 66 1,218,700 1,218,766
Common stock issued as consideration for acquisition, shares   66,454        
Options issued in satisfaction of accrued issuable equity     16,004 16,004
Common stock issued upon cashless warrant exercise   $ 253 (253)
Common stock issued upon cashless warrant exercise, shares   253,038       253,038
Common stock issued upon cashless option exercise   $ 8 (8)
Common stock issued upon cashless option exercise, shares   8,256        
Other comprehensive income       (183,173) (183,173)
Net loss       (17,846,467) (17,846,467)
Balance at Dec. 31, 2020 $ 35,951 $ 214,479,094 $ (187,351,448) $ 27,163,597
Balance, shares at Dec. 31, 2020 35,951,097        
[1] Includes gross proceeds of $19,999,984, less issuance costs of $819,438.